Here are three updates:
1. Jeffries presently has a $48 price target on Orthofix shares.
2. In July, Sidoti gave the shares a “buy rating.”
3. Sidoti has a $43 price target on the company’s shares.
More device news:
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Steven C. Schallhorn tapped as CMO of global ophthalmic devices for Carl Zeiss Meditec: 3 thoughts
Medtronic, Depuy Synthes lead cervical total disc replacement device market: 6 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
